SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006526
Filing Date
2019-05-07
Accepted
2019-05-07 17:25:36
Documents
71
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 681448
2 ex10-1.htm EX-10.1 241578
3 ex10-2.htm EX-10.2 237394
4 ex10-3.htm EX-10.3 185674
5 ex10-4.htm EX-10.4 232525
6 ex10-5.htm EX-10.5 154547
7 ex10-6.htm EX-10.6 229646
8 ex31-1.htm EX-31.1 16785
9 ex31-2.htm EX-31.2 17468
10 ex32-1.htm EX-32.1 9909
11 ex10-6_001.jpg GRAPHIC 1741
12 ex10-6_002.jpg GRAPHIC 1834
  Complete submission text file 0001493152-19-006526.txt   4678087

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE eton-20190331.xml EX-101.INS 424386
14 XBRL SCHEMA FILE eton-20190331.xsd EX-101.SCH 43680
15 XBRL CALCULATION FILE eton-20190331_cal.xml EX-101.CAL 45952
16 XBRL DEFINITION FILE eton-20190331_def.xml EX-101.DEF 174732
17 XBRL LABEL FILE eton-20190331_lab.xml EX-101.LAB 316520
18 XBRL PRESENTATION FILE eton-20190331_pre.xml EX-101.PRE 259067
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 19804270
SIC: 2834 Pharmaceutical Preparations